Unveiling mechanisms of relapse in small cell lung cancer under therapy

Small cell lung cancer (SCLC) is a highly aggressive tumor of the lung that occurs especially in heavy smokers.

Novartis to sell molecular imaging business to Siemens Healthineers

Novartis is selling off its molecular imaging business for positron emission tomography (PET) scans to Siemens Healthineers for an undisclosed amount, both companies confirmed to

August 27, 2024

ESC 2024: New PACMAN-AMI trial analysis sheds insights on Praluent efficacy – Pharmaceutical Technology

Participants in front of the logo of the European Society of Cardiology at a previous meeting. The 2024 conference was held in London 30 August-2

September 5, 2024

Reunion Neuroscience Receives FDA Clearance On IND Application For Postpartum Depression Trial

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.